Chest wall surgery for asphyxiating thoracic surgery.
Our experience to date suggests that LTE is a safe and effective treatment of symptomatic patients with ATD. Patients uniformly are clinically improved. Measured increases in thoracic volume are offset by overall increases in body size keeping the percent of predicted volumes low, suggesting mechanisms other than pure thoracic volume increase to explain the observed clinical improvement. Long term follow-up is mandatory.